ADVERTISEMENT
Decoding Impact Of U.S. Tariffs On Indian Pharma — Read Motilal Oswal's Analysis
The impact of the tariffs, when implemented, would be passed on to US patients pool, thereby increasing the cost of medicine, adds Motilal Oswal
21 Feb 2025, 10:24 AM IST 
Save
While US President Donald Trump is expected to make a detailed announcement on April 02, 2025, there is work-in-progress for a bilateral trade agreement.
Image for representation (Source: Freepik)
India pharma products account for ~44% of the U.S. pharma market by volume and 47% of generics prescriptions. Thus, it would be difficult to replace Indian pharma manufacturers purely by a tariff increase. While US President Donald Trump is expected to make a detailed announcement on April 02, 2025, there is work-in-progress for a bilateral trade agreement.
